Skip to main content

JD Health International Inc. (JDHIF)

OTC Markets (US) Healthcare Medical - Care FacilitiesView data quality →
59.1Fair

ValueMarkers Composite Index

Top 74%#11,762 of 44,707
Overvalued

438% above intrinsic value ($0)

UndervaluedFair ValueOvervalued
Piotroski
6/9
Neutral
Beneish
-3.62
Low Risk
Altman
1.96
Grey Zone
DCF Value
$0
Overvalued
ROIC
5.6%
Low
P/E
24.7
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

JD Health International Inc. (JDHIF) — VMCI valuation read

The headline on JD Health International Inc. (JDHIF) is a 59/100 VMCI score, set against a Healthcare sector median of 50. That 9-point above-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value tailwind is in the data.

JDHIF insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** JDHIF trades at 15.0x earnings, 17% below the Healthcare median of 18.0x sets the value side. ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of -0.1x leaves covenant headroom sets the risk side, the three lines a value buyer reads first on JDHIF.

JDHIF rose 1.9% over the trailing 7 days, with a -13.4% read on a 30-day basis.

JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

CEO: Cao Dong3,564 employeesCNir.jdhealth.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in JDHIF’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.